AdipoPharma

AdipoPharma SAS

This biotech company develops a therapeutic peptide to treat insulin resistance and type 2 diabetes for patients with metabolic diseases.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.

Adipo Therapeutics

This biopharmaceutical company develops Notch-inhibiting nanoparticle therapies that convert white fat into energy-burning brown fat for patients with obesity and Type 2 diabetes.

Zealand Pharma

This biotechnology company develops peptide-based medicines for patients with obesity, rare diseases and chronic inflammation through metabolic health research.

Antag Therapeutics

This company develops GIP receptor antagonist therapies to treat patients living with obesity, type 2 diabetes and metabolic disorders.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.

Genepredit

This biotechnology company develops targeted therapeutics and companion diagnostics for metabolic diseases, specifically focusing on obesity treatments for healthcare providers and pharmaceutical partners.